These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4192239)

  • 1. Plasma proteins after continuous, oral use of a progestogen--chloromadionone acetate--as a contraceptive.
    Laurell CB; Kullander S; Thorell J
    Scand J Clin Lab Invest; 1969 Dec; 24(4):387-9. PubMed ID: 4192239
    [No Abstract]   [Full Text] [Related]  

  • 2. Antithrombin 3 concentration in women using low-dosage progestogen for contraception.
    Bergsjö P; Fagerhol MK; Abildgaard U
    Am J Obstet Gynecol; 1972 Apr; 112(7):938-40. PubMed ID: 4114468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum vitamin B 12 binding capacity and oral contraceptive hormones.
    Bianchine JR; Bonnlander B; Macaraeg PV; Hersey R; Bianchine JW; McIntyre PA
    J Clin Endocrinol Metab; 1969 Nov; 29(11):1425-8. PubMed ID: 4186909
    [No Abstract]   [Full Text] [Related]  

  • 4. [Protein metabolism in women using Femigen Polfa as peroral contraceptives].
    Firek A; Pisarek-Miedzińska D; Wójcicka J; Korc R
    Ginekol Pol; 1973 Nov; 44(11):1303-8. PubMed ID: 4129073
    [No Abstract]   [Full Text] [Related]  

  • 5. Experience with chlormadinone acetate in continuous low dose as an oral contraceptive.
    Jeppsson S; Kullander S
    Fertil Steril; 1970 Apr; 21(4):307-13. PubMed ID: 4101383
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-estrogens and plasma proteins. II. Contraceptive drugs and gestagens.
    Barbosa J; Seal US; Doe RP
    J Clin Endocrinol Metab; 1973 Apr; 36(4):706-14. PubMed ID: 4119677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of combined and low-dose gestagen oral contraceptives on plasma lipids; including individual phospholipids.
    Larsson-Cohn U; Berlin R; Vikrot O
    Acta Endocrinol (Copenh); 1970 Apr; 63(4):717-35. PubMed ID: 4194179
    [No Abstract]   [Full Text] [Related]  

  • 8. Glucose tolerance and insulin response during daily continuous low-dose oral contraceptive treatment.
    Larsson-Cohn U; Tengström B; Wide L
    Acta Endocrinol (Copenh); 1969 Oct; 62(2):242-50. PubMed ID: 4186652
    [No Abstract]   [Full Text] [Related]  

  • 9. Low-dose continuous chlormadinone acetate as an oral contraceptive. A clinical trial.
    Howard G; Blair M; Elstein M; Morris NF
    Lancet; 1969 Jul; 2(7610):24-6. PubMed ID: 4182794
    [No Abstract]   [Full Text] [Related]  

  • 10. Sequential estrogen and progestogen therapy. A clinical evaluation.
    Abrams AA
    Am J Obstet Gynecol; 1966 Dec; 96(7):1005-10. PubMed ID: 4162848
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood clotting and platelet aggregation during oral progestogen contraception: a follow-up study.
    Poller L; Thomson JM; Thomas W; Wray C
    Br Med J; 1971 Mar; 1(5751):705-7. PubMed ID: 4101481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in plasma lipids caused by oral contraceptives].
    Kaffarnik H
    Z Ernahrungswiss Suppl; 1972; 12():Suppl 12:67-72. PubMed ID: 4114609
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lipid metabolism in women ingesting gestagens as contraceptives].
    Pisarek-Miedzińska D; Roszkowski I; Firek A
    Ginekol Pol; 1972; 43(12):1407-19. PubMed ID: 4119343
    [No Abstract]   [Full Text] [Related]  

  • 14. Chlormadinone acetate as an oral contraceptive: clinical results and the incidence of ovulation.
    Macdonald RR; Lumley IB; Coulson A; Stitch SR
    J Obstet Gynaecol Br Commonw; 1968 Nov; 75(11):1123-7. PubMed ID: 4177922
    [No Abstract]   [Full Text] [Related]  

  • 15. [The serum levels of nonesterified fatty acids and free amino acids under the effect of the oral contraceptive, Ovosiston].
    Methfessel HD; Mlytz H; Liedtke MP; Löffler F; Methfessel G
    Z Arztl Fortbild (Jena); 1970 Sep; 64(17):880-2. PubMed ID: 4098228
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of the oral contraceptive Ovosiston on the composition of human milk.
    Ramadan MA; Salah MM; Eid SZ; Sammour MB
    J Reprod Med; 1972 Aug; 9(2):81-3. PubMed ID: 4115112
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of the metabolic effects of chlormadinone acetate and conventional contraceptive steroids in man.
    Beck P
    J Clin Endocrinol Metab; 1970 Jun; 30(6):785-91. PubMed ID: 4192202
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of different types of oral contraceptives on the protein-bound iodine and the 125I-triiodothyronine uptake on sephadex.
    Larsson-Cohn U
    Scand J Clin Lab Invest; 1969 Jun; 23(4):373-8. PubMed ID: 4192237
    [No Abstract]   [Full Text] [Related]  

  • 19. [The action of Sequostat in comparison to Sequence Ovosiston on selected metabolic parameters].
    Etzrodt R; Klinger G; Carol W
    Zentralbl Gynakol; 1990; 112(8):489-96. PubMed ID: 1694614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [1st clinical experiences on the use of oral contraceptive Ovosiston in diabetics].
    Gödel E; Gödel B
    Dtsch Gesundheitsw; 1970 Apr; 25(14):627-31. PubMed ID: 4098543
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.